FAMOTIDINE TABLET, FILM-COATED

FAMOTIDINE TABLET, FILM-COATED was reported 5528 times

FAMOTIDINE TABLET, FILM-COATED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINE AMPHETAMINE 2 0.3333
1 CAECAL LESION EXCISION 1 0.3333
2 BODY TEMPERATURE NORMAL 1 0.1667
3 CARCINOGENICITY 30 0.1240
4 URINE AMPHETAMINE POSITIVE 36 0.1098
5 ACCIDENTAL DRUG INTAKE BY CHILD 92 0.0599
6 BIOPSY CERVIX ABNORMAL 1 0.0455
7 AMPHETAMINES POSITIVE 33 0.0441
8 FALSE POSITIVE LABORATORY RESULT 4 0.0215
9 DRUG SCREEN FALSE POSITIVE 50 0.0181
10 CENTRAL NERVOUS SYSTEM INJURY 1 0.0154
11 ACHLORHYDRIA 1 0.0143
12 BACTERIAL CULTURE POSITIVE 1 0.0141
13 NO ADVERSE REACTION 2 0.0137
14 COLON CANCER STAGE I 2 0.0115
15 DRUG SCREEN POSITIVE 81 0.0102
16 RENAL HAEMANGIOMA 8 0.0100
17 PRODUCT ADVERTISING ISSUE 2 0.0093
18 PHYSICAL DISABILITY 35 0.0079
19 BLOOD GASTRIN INCREASED 1 0.0078
20 BUCCAL MUCOSAL ROUGHENING 1 0.0070
21 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
22 OPIATES POSITIVE 3 0.0063
23 ACID FAST BACILLI INFECTION 1 0.0062
24 ACCIDENTAL EXPOSURE 25 0.0060
25 METASTATIC GASTRIC CANCER 2 0.0058
26 INFANTILE SPITTING UP 3 0.0057
27 URINE COLOUR ABNORMAL 3 0.0053
28 CRYPTOGENIC ORGANIZING PNEUMONIA 1 0.0052
29 LABORATORY TEST INTERFERENCE 4 0.0051
30 END STAGE RENAL DISEASE 89 0.0049
31 REACTION TO COLOURING 2 0.0049
32 CATHETER SEPSIS 1 0.0048
33 COMPLICATIONS OF TRANSPLANTED HEART 1 0.0047
34 REBOUND ACID HYPERSECRETION 14 0.0046
35 COLON CANCER STAGE II 1 0.0045
36 CHRONIC KIDNEY DISEASE 342 0.0045
37 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
38 EXPOSURE DURING PREGNANCY 267 0.0043
39 SALIVARY GLAND DISORDER 2 0.0043
40 CARDIAC FAILURE HIGH OUTPUT 1 0.0041
41 FOREIGN BODY TRAUMA 3 0.0041
42 ADENOTONSILLECTOMY 1 0.0040
43 COLITIS COLLAGENOUS 1 0.0039
44 FAECAL VOLUME INCREASED 2 0.0038
45 STOMACH DISCOMFORT 19 0.0037
46 DENTAL PLAQUE 1 0.0036
47 LIFE EXPECTANCY SHORTENED 2 0.0035
48 BIOPSY LIVER ABNORMAL 1 0.0033
49 OESOPHAGEAL PAIN 13 0.0033
50 THERAPEUTIC PRODUCT EFFECT DELAYED 15 0.0033
51 INCORRECT DRUG DOSAGE FORM ADMINISTERED 2 0.0033
52 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
53 NIPPLE DISORDER 2 0.0032
54 URTICARIA GENERALISED 2 0.0031
55 ACCIDENTAL OVERDOSE 111 0.0030
56 NEPHROGENIC ANAEMIA 14 0.0030
57 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
58 DRUG EXPOSURE BEFORE PREGNANCY 3 0.0030
59 ACQUIRED OESOPHAGEAL WEB 1 0.0029
60 COLONIC STENOSIS 1 0.0029
61 FAECES DISCOLOURED 62 0.0029
62 IMPAIRED QUALITY OF LIFE 41 0.0028
63 PERINEAL PAIN 2 0.0028
64 BIPOLAR II DISORDER 1 0.0028
65 CATHETER RELATED COMPLICATION 3 0.0027
66 REFLUX OESOPHAGITIS 2 0.0026
67 COLON CANCER STAGE III 1 0.0026
68 BLOOD ALCOHOL INCREASED 2 0.0026
69 PRODUCT CONFUSION 2 0.0025
70 DISEASE RISK FACTOR 1 0.0025
71 HYPERPARATHYROIDISM SECONDARY 6 0.0024
72 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
73 BONE NEOPLASM MALIGNANT 1 0.0024
74 HYPERCHLORHYDRIA 14 0.0024
75 GLIOBLASTOMA MULTIFORME 2 0.0024
76 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
77 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
78 DYSPEPSIA 227 0.0023
79 ABDOMINAL NEOPLASM 2 0.0022
80 SALIVA ALTERED 2 0.0022
81 ARTERIOVENOUS MALFORMATION 2 0.0022
82 CIRRHOSIS ALCOHOLIC 1 0.0022
83 NASAL CAVITY CANCER 2 0.0022
84 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 1 0.0022
85 METASTASES TO ADRENALS 2 0.0022
86 BODY MASS INDEX DECREASED 1 0.0022
87 FOETAL HEART RATE ABNORMAL 2 0.0022
88 THERAPEUTIC RESPONSE DELAYED 6 0.0021
89 ERUCTATION 41 0.0021
90 HEPATIC CONGESTION 2 0.0021
91 PRODUCT AFTER TASTE 2 0.0021
92 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 3 0.0021
93 BRAIN DAMAGE 1 0.0020
94 BREAST CANCER MALE 1 0.0020
95 GASTRIC PH DECREASED 2 0.0020
96 ACCIDENT AT HOME 1 0.0019
97 OROPHARYNGEAL BLISTERING 3 0.0018
98 PILOERECTION 2 0.0018
99 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
100 TESTIS CANCER 7 0.0018
101 NEUROPATHY 3 0.0018
102 REGURGITATION 6 0.0017
103 MILIARIA 3 0.0017
104 PHARYNGEAL INFLAMMATION 2 0.0016
105 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
106 COLON CANCER 24 0.0016
107 TUBULOINTERSTITIAL NEPHRITIS 30 0.0016
108 GASTROOESOPHAGEAL REFLUX DISEASE 128 0.0016
109 TRISOMY 21 2 0.0016
110 EXPOSURE VIA INGESTION 4 0.0016
111 EXPOSURE TO TOXIC AGENT 5 0.0016
112 ANOXIC ENCEPHALOPATHY 1 0.0016
113 CELLULITIS STAPHYLOCOCCAL 1 0.0015
114 MULTI-ORGAN DISORDER 3 0.0015
115 RENAL INJURY 44 0.0015
116 ABSCESS NECK 1 0.0015
117 INJURY 102 0.0014
118 BRAIN CANCER METASTATIC 1 0.0014
119 DERMATITIS DIAPER 1 0.0014
120 CARDIAC ENZYMES INCREASED 1 0.0014
121 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
122 THERAPEUTIC REACTION TIME DECREASED 4 0.0014
123 ACCOMMODATION DISORDER 1 0.0014
124 TEMPERATURE REGULATION DISORDER 3 0.0013
125 SMALL INTESTINE CARCINOMA 3 0.0013
126 FLATULENCE 75 0.0013
127 DEBRIDEMENT 1 0.0013
128 OESOPHAGEAL DISORDER 5 0.0013
129 NON-CARDIAC CHEST PAIN 4 0.0013
130 FOREIGN BODY 5 0.0012
131 FAECAL INCONTINENCE 6 0.0012
132 BARRETT'S OESOPHAGUS 1 0.0012
133 ORAL INTAKE REDUCED 3 0.0012
134 ALLERGIC GRANULOMATOUS ANGIITIS 1 0.0012
135 EXPIRED DRUG ADMINISTERED 6 0.0012
136 VENA CAVA THROMBOSIS 2 0.0012
137 CULTURE POSITIVE 1 0.0012
138 SENSATION OF FOREIGN BODY 10 0.0012
139 GASTRIC CANCER 30 0.0012
140 APTYALISM 1 0.0012
141 TONGUE COATED 2 0.0012
142 BLOOD CHLORIDE INCREASED 2 0.0012
143 WOUND INFECTION STAPHYLOCOCCAL 2 0.0012
144 GLOSSITIS 4 0.0011
145 FEAR OF DISEASE 2 0.0011
146 SCHIZOAFFECTIVE DISORDER 2 0.0011
147 PRURITUS GENERALISED 24 0.0011
148 INCORRECT DRUG ADMINISTRATION DURATION 31 0.0011
149 ACUTE KIDNEY INJURY 166 0.0011
150 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
151 RENAL FAILURE 143 0.0011
152 BONE GRAFT 1 0.0011
153 RENAL CANCER 51 0.0011
154 HEPATIC MASS 2 0.0010
155 VOMITING PROJECTILE 3 0.0010
156 MUSCLE RUPTURE 4 0.0010
157 STRIDOR 3 0.0010
158 DECREASED INTEREST 6 0.0010
159 RENAL CYST 8 0.0010
160 LUNG ADENOCARCINOMA 3 0.0010
161 NEOPLASM MALIGNANT 66 0.0010
162 VITAMIN B12 DEFICIENCY 4 0.0010
163 TENSION 6 0.0010
164 RENAL MASS 2 0.0010
165 VENOUS THROMBOSIS LIMB 2 0.0010
166 ABSCESS JAW 1 0.0010
167 LIVEDO RETICULARIS 2 0.0010
168 BLAST CELL COUNT INCREASED 1 0.0010
169 THROAT CANCER 4 0.0009
170 RENAL NEOPLASM 2 0.0009
171 ASTERIXIS 1 0.0009
172 ANOREXIA 12 0.0009
173 GASTRIC CANCER STAGE IV 2 0.0009
174 CHROMATURIA 21 0.0009
175 OEDEMA MOUTH 3 0.0009
176 ANHEDONIA 24 0.0009
177 COMPLEX PARTIAL SEIZURES 1 0.0009
178 BLADDER CANCER 53 0.0009
179 POTENTIATING DRUG INTERACTION 3 0.0009
180 OESOPHAGEAL CARCINOMA 26 0.0009
181 ORAL PRURITUS 2 0.0009
182 CEREBRAL VENTRICLE DILATATION 1 0.0009
183 ACUTE PRERENAL FAILURE 1 0.0009
184 NEPHROPATHY 8 0.0009
185 HICCUPS 7 0.0009
186 COLORECTAL CANCER METASTATIC 2 0.0008
187 BILE DUCT CANCER 1 0.0008
188 LACUNAR INFARCTION 2 0.0008
189 KIDNEY TRANSPLANT REJECTION 4 0.0008
190 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
191 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
192 REBOUND EFFECT 9 0.0008
193 PANCREATIC CARCINOMA 23 0.0008
194 BRADYCARDIA NEONATAL 1 0.0008
195 DRUG INEFFECTIVE 1038 0.0008
196 FEELING JITTERY 15 0.0008
197 INCREASED UPPER AIRWAY SECRETION 4 0.0008
198 CALCIUM DEFICIENCY 1 0.0008
199 HIATUS HERNIA 10 0.0008
200 FAECES HARD 3 0.0008
201 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
202 ASPERGILLOSIS 1 0.0008
203 PHARYNGOLARYNGEAL PAIN 4 0.0008
204 YAWNING 2 0.0007
205 DEFORMITY 7 0.0007
206 PRODUCT SIZE ISSUE 4 0.0007
207 GALLBLADDER OPERATION 3 0.0007
208 EAR CONGESTION 2 0.0007
209 PRODUCT PACKAGING ISSUE 7 0.0007
210 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
211 GASTRIC PERFORATION 2 0.0007
212 BLOOD PHOSPHORUS INCREASED 2 0.0007
213 ABSCESS ORAL 1 0.0007
214 ECONOMIC PROBLEM 11 0.0007
215 APPLICATION SITE INFLAMMATION 1 0.0007
216 CULTURE URINE POSITIVE 1 0.0007
217 ALVEOLITIS 1 0.0007
218 GENERALISED ERYTHEMA 4 0.0007
219 LUNG NEOPLASM 3 0.0007
220 THROAT TIGHTNESS 19 0.0007
221 ABDOMINAL PAIN UPPER 144 0.0007
222 TONGUE DISORDER 5 0.0007
223 SKIN WARM 4 0.0007
224 TONGUE DISCOLOURATION 3 0.0007
225 TOOTH DISCOLOURATION 2 0.0007
226 THERAPEUTIC RESPONSE DECREASED 41 0.0007
227 UNEVALUABLE EVENT 51 0.0007
228 BRAIN HERNIATION 2 0.0007
229 URINE ANALYSIS ABNORMAL 2 0.0007
230 DRUG EFFECT DECREASED 36 0.0007
231 VARICES OESOPHAGEAL 2 0.0007
232 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
233 ANXIETY 186 0.0007
234 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
235 RECTAL CANCER 2 0.0007
236 PHARYNGEAL OEDEMA 10 0.0006
237 MULTIPLE MYELOMA 3 0.0006
238 GASTRITIS EROSIVE 3 0.0006
239 BRONCHIAL DISORDER 1 0.0006
240 YELLOW SKIN 3 0.0006
241 LEUKAEMIA 6 0.0006
242 INFUSION SITE PRURITUS 2 0.0006
243 DYSGEUSIA 47 0.0006
244 BLADDER PAIN 2 0.0006
245 EMOTIONAL DISTRESS 76 0.0006
246 THROAT IRRITATION 28 0.0006
247 BLADDER CANCER STAGE II 1 0.0006
248 RASH GENERALISED 16 0.0006
249 COSTOCHONDRITIS 1 0.0006
250 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
251 RENAL CELL CARCINOMA 3 0.0006
252 COELIAC DISEASE 6 0.0006
253 ABNORMAL FAECES 5 0.0006
254 MUCOUS STOOLS 3 0.0006
255 PEPTIC ULCER 2 0.0006
256 ANXIETY DISORDER 2 0.0006
257 BLADDER CANCER STAGE IV 1 0.0006
258 DRUG TOLERANCE 3 0.0006
259 TONGUE ULCERATION 2 0.0006
260 CLOSTRIDIAL INFECTION 2 0.0006
261 COLORECTAL CANCER 28 0.0006
262 PRODUCT COLOUR ISSUE 3 0.0006
263 BLOOD AMYLASE INCREASED 1 0.0006
264 HEPATIC CANCER 14 0.0006
265 ORAL DISCOMFORT 8 0.0006
266 INTENTIONAL DRUG MISUSE 12 0.0006
267 LIP SWELLING 19 0.0006
268 ULCER 9 0.0006
269 BREAST CYST 1 0.0006
270 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
271 HAEMORRHAGIC DIATHESIS 2 0.0006
272 FACIAL BONES FRACTURE 2 0.0006
273 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
274 PROSTATE CANCER 44 0.0005
275 FOOD INTOLERANCE 2 0.0005
276 STREPTOCOCCAL INFECTION 3 0.0005
277 LEUKOENCEPHALOPATHY 2 0.0005
278 AURA 1 0.0005
279 BLOOD IRON INCREASED 1 0.0005
280 FACE INJURY 2 0.0005
281 VISUAL DISTURBANCE 3 0.0005
282 FOOD ALLERGY 4 0.0005
283 DRY MOUTH 42 0.0005
284 PRODUCT TASTE ABNORMAL 7 0.0005
285 NERVOUSNESS 27 0.0005
286 ALCOHOL INTERACTION 1 0.0005
287 APNOEA 4 0.0005
288 CONCOMITANT DISEASE PROGRESSION 1 0.0005
289 PATENT DUCTUS ARTERIOSUS 2 0.0005
290 ODYNOPHAGIA 3 0.0005
291 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
292 PROTHROMBIN TIME PROLONGED 3 0.0005
293 SALIVARY HYPERSECRETION 5 0.0005
294 DRY THROAT 5 0.0005
295 GLOSSODYNIA 11 0.0005
296 DRUG ADMINISTRATION ERROR 15 0.0005
297 CHANGE OF BOWEL HABIT 1 0.0005
298 PIGMENTATION DISORDER 3 0.0005
299 MEDICATION ERROR 27 0.0005
300 NASAL DRYNESS 3 0.0005
301 MULTIPLE INJURIES 3 0.0005
302 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
303 SCREAMING 3 0.0005
304 IMPAIRED WORK ABILITY 10 0.0005
305 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
306 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
307 POLYP 3 0.0005
308 CERVICAL DYSPLASIA 1 0.0005
309 DRUG DISPENSING ERROR 7 0.0005
310 URINE OUTPUT DECREASED 4 0.0005
311 BIPOLAR I DISORDER 1 0.0005
312 DIABETIC NEPHROPATHY 1 0.0005
313 CONSTIPATION 99 0.0005
314 ACCIDENT AT WORK 1 0.0005
315 MUSCULOSKELETAL CHEST PAIN 7 0.0005
316 FREQUENT BOWEL MOVEMENTS 12 0.0004
317 BLOOD LOSS ANAEMIA 1 0.0004
318 DRUG EFFECT DELAYED 2 0.0004
319 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
320 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
321 ARTHRITIS INFECTIVE 2 0.0004
322 BILIRUBIN CONJUGATED INCREASED 1 0.0004
323 CHEST PAIN 79 0.0004
324 DUODENAL ULCER 3 0.0004
325 RETCHING 9 0.0004
326 ABDOMINAL DISTENSION 44 0.0004
327 MUSCULOSKELETAL PAIN 22 0.0004
328 GASTRITIS 11 0.0004
329 APHAGIA 2 0.0004
330 ATELECTASIS 4 0.0004
331 MAJOR DEPRESSION 3 0.0004
332 PSYCHIATRIC SYMPTOM 3 0.0004
333 DISABILITY 8 0.0004
334 HAEMATOCRIT DECREASED 8 0.0004
335 HEART RATE IRREGULAR 9 0.0004
336 COLORECTAL CANCER STAGE III 2 0.0004
337 COLD SWEAT 7 0.0004
338 PRODUCT ADMINISTRATION ERROR 8 0.0004
339 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
340 DYSPHORIA 2 0.0004
341 URTICARIA 66 0.0004
342 MOTOR DYSFUNCTION 4 0.0004
343 BOWEL MOVEMENT IRREGULARITY 3 0.0004
344 ABDOMINAL INFECTION 1 0.0004
345 ABNORMAL UTERINE BLEEDING 1 0.0004
346 AORTIC ARTERIOSCLEROSIS 1 0.0004
347 BLOOD CHLORIDE DECREASED 1 0.0004
348 FOETAL DEATH 2 0.0004
349 APLASTIC ANAEMIA 2 0.0004
350 DYSURIA 14 0.0004
351 SERUM FERRITIN INCREASED 2 0.0004
352 GASTRIC DISORDER 13 0.0004
353 NASAL DISCOMFORT 3 0.0004
354 RENAL PAIN 4 0.0004
355 ANORECTAL DISCOMFORT 2 0.0004
356 ABDOMINAL DISCOMFORT 63 0.0004
357 ANGIONEUROTIC OEDEMA 1 0.0004
358 QUALITY OF LIFE DECREASED 5 0.0004
359 URINARY INCONTINENCE 11 0.0004
360 GINGIVITIS 2 0.0004
361 BURNING SENSATION 26 0.0004
362 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
363 ABDOMINAL RIGIDITY 1 0.0004
364 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
365 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
366 ABNORMAL DREAMS 10 0.0004
367 FEELING COLD 10 0.0004
368 INTRACRANIAL PRESSURE INCREASED 2 0.0004
369 ORAL PAIN 8 0.0004
370 DIABETIC COMA 1 0.0004
371 ANAL HAEMORRHAGE 1 0.0004
372 SNEEZING 8 0.0004
373 BLOOD CALCIUM DECREASED 4 0.0004
374 HAEMATEMESIS 9 0.0004
375 SWELLING FACE 23 0.0004
376 CEREBRAL THROMBOSIS 1 0.0004
377 BREAST CANCER STAGE IV 1 0.0004
378 SWOLLEN TONGUE 11 0.0004
379 CORONARY ARTERY BYPASS 2 0.0003
380 PYELONEPHRITIS 3 0.0003
381 HYPERVENTILATION 2 0.0003
382 HYPERHIDROSIS 44 0.0003
383 URINE ODOUR ABNORMAL 2 0.0003
384 RESPIRATORY RATE INCREASED 3 0.0003
385 CATARACT OPERATION 2 0.0003
386 BREAST CANCER FEMALE 9 0.0003
387 IMMUNODEFICIENCY 5 0.0003
388 THYROID CANCER 4 0.0003
389 HYPOAESTHESIA ORAL 5 0.0003
390 DIARRHOEA 214 0.0003
391 GASTROINTESTINAL CARCINOMA 3 0.0003
392 BURSITIS 4 0.0003
393 NOCTURIA 4 0.0003
394 NO THERAPEUTIC RESPONSE 4 0.0003
395 VOMITING 154 0.0003
396 FEELING HOT 20 0.0003
397 CHEST X-RAY ABNORMAL 1 0.0003
398 OVARIAN CANCER 3 0.0003
399 GRAND MAL CONVULSION 3 0.0003
400 DIZZINESS 162 0.0003
401 LARYNGEAL OEDEMA 2 0.0003
402 OVERDOSE 70 0.0003
403 TOOTH EXTRACTION 4 0.0003
404 EXTRA DOSE ADMINISTERED 13 0.0003
405 GASTRIC ULCER 6 0.0003
406 BILE DUCT STONE 1 0.0003
407 INCREASED APPETITE 6 0.0003
408 CHEST DISCOMFORT 32 0.0003
409 MYDRIASIS 4 0.0003
410 HAEMOGLOBIN ABNORMAL 2 0.0003
411 BREAST CANCER STAGE III 2 0.0003
412 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
413 ANGINA UNSTABLE 2 0.0003
414 PRODUCT AVAILABILITY ISSUE 7 0.0003
415 BODY TEMPERATURE DECREASED 3 0.0003
416 HYPOGAMMAGLOBULINAEMIA 2 0.0003
417 PAIN 186 0.0003
418 APPETITE DISORDER 2 0.0003
419 EXPIRED PRODUCT ADMINISTERED 10 0.0003
420 POST-TRAUMATIC STRESS DISORDER 2 0.0003
421 BREAST MASS 2 0.0003
422 EYE PRURITUS 10 0.0003
423 BRONCHIECTASIS 2 0.0003
424 VAGINAL DISCHARGE 3 0.0003
425 POSTOPERATIVE WOUND INFECTION 2 0.0003
426 WRONG PRODUCT ADMINISTERED 2 0.0003
427 RASH PRURITIC 16 0.0003
428 PRODUCT LABEL ISSUE 2 0.0003
429 DRUG TOXICITY 4 0.0003
430 ABNORMAL LOSS OF WEIGHT 2 0.0003
431 INITIAL INSOMNIA 3 0.0003
432 EYE MOVEMENT DISORDER 2 0.0003
433 BRONCHOPNEUMONIA 1 0.0003
434 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
435 PERIPHERAL COLDNESS 4 0.0003
436 TENDERNESS 3 0.0003
437 POLLAKIURIA 12 0.0003
438 AORTIC STENOSIS 1 0.0003
439 CAROTID ARTERY STENOSIS 1 0.0003
440 RIGHT VENTRICULAR FAILURE 2 0.0003
441 BRONCHIOLITIS 1 0.0003
442 PAIN IN JAW 8 0.0003
443 EATING DISORDER 6 0.0003
444 NO ADVERSE EVENT 51 0.0003
445 DRY EYE 14 0.0003
446 RECTAL HAEMORRHAGE 12 0.0003
447 DECREASED ACTIVITY 3 0.0003
448 PARAESTHESIA ORAL 4 0.0003
449 BIPOLAR DISORDER 3 0.0003
450 RESTLESS LEGS SYNDROME 5 0.0003
451 GASTROINTESTINAL PAIN 3 0.0003
452 DENTAL CARIES 3 0.0003
453 SKIN DISORDER 9 0.0003
454 TOOTH DISORDER 6 0.0003
455 FEELING DRUNK 2 0.0003
456 EYE SWELLING 10 0.0003
457 BLOOD PRESSURE INCREASED 41 0.0003
458 HYDRONEPHROSIS 2 0.0003
459 PRURITUS 102 0.0003
460 DYSPHAGIA 25 0.0003
461 MICTURITION URGENCY 3 0.0003
462 COMMUNICATION DISORDER 1 0.0003
463 CLAVICLE FRACTURE 1 0.0003
464 MUSCLE TWITCHING 6 0.0003
465 RENAL FAILURE CHRONIC 2 0.0003
466 INSOMNIA 69 0.0003
467 INCORRECT DOSE ADMINISTERED 59 0.0003
468 TENDONITIS 4 0.0003
469 SPLENOMEGALY 3 0.0003
470 WHEEZING 15 0.0003
471 SINUS DISORDER 5 0.0003
472 GINGIVAL PAIN 2 0.0003
473 HAEMOPTYSIS 7 0.0003
474 TRANSPLANT REJECTION 2 0.0002
475 CANDIDIASIS 1 0.0002
476 SENSORY DISTURBANCE 4 0.0002
477 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
478 UTERINE CANCER 2 0.0002
479 NAUSEA 196 0.0002
480 MUSCLE DISORDER 2 0.0002
481 MUSCLE TIGHTNESS 4 0.0002
482 BLOOD POTASSIUM INCREASED 4 0.0002
483 DISCOMFORT 15 0.0002
484 DEMYELINATION 1 0.0002
485 ESCHERICHIA INFECTION 2 0.0002
486 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
487 MUSCLE INJURY 2 0.0002
488 EMBOLISM 2 0.0002
489 COAGULOPATHY 4 0.0002
490 CONGESTIVE CARDIOMYOPATHY 1 0.0002
491 HAEMODIALYSIS 2 0.0002
492 RENAL DISORDER 11 0.0002
493 AORTIC VALVE INCOMPETENCE 1 0.0002
494 ROTATOR CUFF SYNDROME 3 0.0002
495 PSEUDOMONAS INFECTION 2 0.0002
496 NECK PAIN 13 0.0002
497 MUSCULOSKELETAL DISCOMFORT 4 0.0002
498 MUSCLE STRAIN 2 0.0002
499 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
500 CHAPPED LIPS 1 0.0002
501 FEELING ABNORMAL 55 0.0002
502 BLOOD CALCIUM INCREASED 2 0.0002
503 METASTASES TO LIVER 4 0.0002
504 OROPHARYNGEAL PAIN 21 0.0002
505 ADVERSE REACTION 3 0.0002
506 CATHETERISATION CARDIAC 1 0.0002
507 BREAST CANCER 21 0.0002
508 WRONG DRUG ADMINISTERED 2 0.0002
509 DYSKINESIA 9 0.0002
510 OROPHARYNGEAL DISCOMFORT 2 0.0002
511 LIP DRY 2 0.0002
512 CORONARY ARTERY OCCLUSION 3 0.0002
513 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
514 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
515 RETINAL DETACHMENT 2 0.0002
516 TREMOR 36 0.0002
517 COLORECTAL CANCER STAGE IV 1 0.0002
518 NERVE COMPRESSION 2 0.0002
519 RHINORRHOEA 14 0.0002
520 THINKING ABNORMAL 4 0.0002
521 ERYTHEMA MULTIFORME 2 0.0002
522 OEDEMA PERIPHERAL 26 0.0002
523 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
524 SKIN REACTION 3 0.0002
525 LACERATION 2 0.0002
526 HEART RATE INCREASED 21 0.0002
527 DIALYSIS 3 0.0002
528 SPUTUM DISCOLOURED 2 0.0002
529 DEHYDRATION 28 0.0002
530 ANGINA PECTORIS 6 0.0002
531 RASH ERYTHEMATOUS 10 0.0002
532 PULMONARY FIBROSIS 4 0.0002
533 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
534 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
535 DIZZINESS POSTURAL 2 0.0002
536 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
537 CHOKING 4 0.0002
538 NASAL CONGESTION 12 0.0002
539 HEADACHE 128 0.0002
540 RENAL TUBULAR NECROSIS 2 0.0002
541 SOMNOLENCE 41 0.0002
542 ACUTE MYOCARDIAL INFARCTION 6 0.0002
543 BLADDER DISORDER 2 0.0002
544 ABDOMINAL TENDERNESS 1 0.0002
545 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
546 CORONARY ARTERY STENOSIS 1 0.0002
547 OSTEOPENIA 3 0.0002
548 VERTIGO 12 0.0002
549 SLUGGISHNESS 2 0.0002
550 BLOOD PRESSURE DECREASED 13 0.0002
551 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
552 HEPATITIS 5 0.0002
553 EUPHORIC MOOD 2 0.0002
554 LUNG NEOPLASM MALIGNANT 8 0.0002
555 HELICOBACTER INFECTION 2 0.0002
556 LYMPHOMA 3 0.0002
557 TEMPERATURE INTOLERANCE 2 0.0002
558 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
559 DELUSION 3 0.0002
560 VENTRICULAR EXTRASYSTOLES 2 0.0002
561 PRODUCT SUBSTITUTION ISSUE 11 0.0002
562 PRODUCT ODOUR ABNORMAL 2 0.0002
563 PARAESTHESIA 30 0.0002
564 RENAL IMPAIRMENT 16 0.0002
565 ABDOMINAL PAIN 44 0.0002
566 MIGRAINE 18 0.0002
567 HYPERSENSITIVITY 35 0.0002
568 RENAL FAILURE ACUTE 8 0.0002
569 BLOOD GLUCOSE DECREASED 9 0.0002
570 ANAL FISSURE 1 0.0002
571 PAIN OF SKIN 5 0.0002
572 ANAL ABSCESS 1 0.0002
573 DEPRESSION 42 0.0002
574 OEDEMA 10 0.0002
575 SLEEP DISORDER 13 0.0002
576 SKIN LACERATION 2 0.0002
577 PALLOR 5 0.0002
578 OESOPHAGITIS 2 0.0002
579 CHOLELITHIASIS 6 0.0002
580 OSTEONECROSIS 6 0.0002
581 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
582 MELAENA 4 0.0002
583 CHOKING SENSATION 1 0.0002
584 DRUG LEVEL INCREASED 3 0.0002
585 HAEMATOCHEZIA 10 0.0002
586 RESPIRATORY DISTRESS 5 0.0002
587 ANAPHYLACTIC REACTION 10 0.0002
588 CONDITION AGGRAVATED 55 0.0002
589 BLOOD UREA INCREASED 3 0.0002
590 INTESTINAL PERFORATION 2 0.0002
591 PANCREATITIS ACUTE 4 0.0002
592 CHOLECYSTECTOMY 2 0.0002
593 INTERNAL HAEMORRHAGE 2 0.0002
594 CONVULSION 10 0.0002
595 SHOCK 4 0.0002
596 HYPOAESTHESIA 26 0.0002
597 BLOOD URIC ACID INCREASED 1 0.0002
598 METASTASES TO LUNG 2 0.0002
599 LOCAL SWELLING 3 0.0002
600 DYSPHONIA 10 0.0002
601 BACTERAEMIA 2 0.0002
602 ATAXIA 2 0.0002
603 GALLBLADDER DISORDER 3 0.0002
604 PRODUCT PRESCRIBING ERROR 4 0.0002
605 CHOLECYSTITIS 2 0.0002
606 BACK PAIN 39 0.0002
607 WRIST FRACTURE 2 0.0002
608 HEPATIC FAILURE 5 0.0002
609 LACRIMATION INCREASED 5 0.0002
610 INTERSTITIAL LUNG DISEASE 8 0.0002
611 CRYING 6 0.0002
612 PRESYNCOPE 4 0.0002
613 DERMATITIS ACNEIFORM 1 0.0002
614 RESPIRATORY DEPRESSION 2 0.0002
615 LIVER INJURY 4 0.0002
616 CARDIOMEGALY 2 0.0002
617 PALPITATIONS 19 0.0002
618 INJECTION SITE EXTRAVASATION 2 0.0002
619 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
620 AGRANULOCYTOSIS 3 0.0002
621 HEPATIC ENZYME INCREASED 11 0.0002
622 PHARYNGITIS 2 0.0002
623 MIDDLE INSOMNIA 3 0.0002
624 INTENTIONAL PRODUCT MISUSE 14 0.0002
625 HYPONATRAEMIA 9 0.0002
626 HEPATIC CIRRHOSIS 3 0.0002
627 PHOTOPHOBIA 3 0.0002
628 DERMATITIS ALLERGIC 2 0.0002
629 BLEPHAROSPASM 1 0.0002
630 BLOOD URINE PRESENT 3 0.0002
631 TACHYCARDIA 14 0.0002
632 FLUID RETENTION 8 0.0002
633 CYSTITIS 5 0.0002
634 INTRAOCULAR PRESSURE INCREASED 2 0.0002
635 LETHARGY 9 0.0002
636 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
637 ERECTILE DYSFUNCTION 4 0.0002
638 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
639 MALAISE 68 0.0002
640 UNRESPONSIVE TO STIMULI 4 0.0002
641 CARDIAC FLUTTER 1 0.0002
642 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
643 EAR PAIN 3 0.0002
644 WEIGHT DECREASED 43 0.0002
645 ATRIAL FIBRILLATION 15 0.0002
646 ORAL HERPES 3 0.0002
647 BLOOD CREATININE INCREASED 10 0.0002
648 KIDNEY INFECTION 3 0.0002
649 MENORRHAGIA 3 0.0002
650 MUSCLE SPASMS 28 0.0002
651 ORAL CANDIDIASIS 2 0.0002
652 STAPHYLOCOCCAL INFECTION 5 0.0002
653 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
654 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
655 BLOOD PRESSURE ABNORMAL 3 0.0002
656 VIRAL INFECTION 5 0.0002
657 JAUNDICE 4 0.0001
658 STOMATITIS 9 0.0001
659 DISTURBANCE IN ATTENTION 8 0.0001
660 COLITIS ISCHAEMIC 1 0.0001
661 ILL-DEFINED DISORDER 9 0.0001
662 BLOOD BILIRUBIN INCREASED 4 0.0001
663 PLEURAL EFFUSION 9 0.0001
664 PULMONARY EMBOLISM 14 0.0001
665 TACHYPNOEA 2 0.0001
666 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
667 EPISTAXIS 11 0.0001
668 RASH 64 0.0001
669 GINGIVAL BLEEDING 2 0.0001
670 ACUTE HEPATIC FAILURE 2 0.0001
671 BLOOD TESTOSTERONE DECREASED 1 0.0001
672 HALLUCINATION 11 0.0001
673 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
674 GASTROINTESTINAL DISORDER 13 0.0001
675 RESPIRATORY ARREST 4 0.0001
676 MENTAL STATUS CHANGES 4 0.0001
677 NEOPLASM PROGRESSION 5 0.0001
678 MASS 2 0.0001
679 MOUTH ULCERATION 3 0.0001
680 HYPOXIA 5 0.0001
681 ERYTHEMA 29 0.0001
682 PLATELET COUNT DECREASED 15 0.0001
683 DIVERTICULUM 1 0.0001
684 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
685 LIVER FUNCTION TEST INCREASED 3 0.0001
686 PARALYSIS 2 0.0001
687 HYPOACUSIS 6 0.0001
688 AMNESIA 9 0.0001
689 DERMATITIS BULLOUS 1 0.0001
690 SEPTIC SHOCK 6 0.0001
691 MENTAL DISORDER 6 0.0001
692 ALOPECIA 27 0.0001
693 GASTROENTERITIS 2 0.0001
694 HAEMOGLOBIN DECREASED 14 0.0001
695 BLINDNESS TRANSIENT 1 0.0001
696 LABORATORY TEST ABNORMAL 4 0.0001
697 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
698 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
699 LIVER DISORDER 6 0.0001
700 CONTUSION 13 0.0001
701 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
702 DYSPNOEA 76 0.0001
703 RASH PAPULAR 3 0.0001
704 RESPIRATORY DISORDER 4 0.0001
705 ASTHENIA 50 0.0001
706 BREAST TENDERNESS 1 0.0001
707 PANCREATITIS 7 0.0001
708 HYPERTENSION 28 0.0001
709 CORONARY ARTERY DISEASE 4 0.0001
710 NEPHROLITHIASIS 6 0.0001
711 DEVICE RELATED INFECTION 2 0.0001
712 PERICARDIAL EFFUSION 3 0.0001
713 THYROID DISORDER 2 0.0001
714 MYALGIA 22 0.0001
715 CONGENITAL ANOMALY 1 0.0001
716 BLOOD CHOLESTEROL INCREASED 6 0.0001
717 SWELLING 12 0.0001
718 CHILLS 15 0.0001
719 BLOOD GLUCOSE INCREASED 24 0.0001
720 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
721 AFFECTIVE DISORDER 1 0.0001
722 CYANOSIS 2 0.0001
723 PRODUCT USE COMPLAINT 2 0.0001
724 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
725 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
726 DISORIENTATION 5 0.0001
727 BLOOD ALBUMIN DECREASED 1 0.0001
728 MOOD SWINGS 4 0.0001
729 MULTIPLE SCLEROSIS 6 0.0001
730 ATRIAL FLUTTER 1 0.0001
731 BLOOD PRESSURE FLUCTUATION 3 0.0001
732 BLOOD DISORDER 1 0.0001
733 COUGH 35 0.0001
734 HIP FRACTURE 4 0.0001
735 JOINT SWELLING 15 0.0001
736 MENTAL IMPAIRMENT 3 0.0001
737 URINARY TRACT INFECTION 21 0.0001
738 DECUBITUS ULCER 1 0.0001
739 METASTASES TO BONE 2 0.0001
740 OSTEOPOROSIS 5 0.0001
741 ABASIA 3 0.0001
742 ACUTE CORONARY SYNDROME 1 0.0001
743 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
744 AGEUSIA 3 0.0001
745 PNEUMONIA ASPIRATION 3 0.0001
746 URINARY RETENTION 4 0.0001
747 GAIT INABILITY 4 0.0001
748 CARDIO-RESPIRATORY ARREST 5 0.0001
749 SURGERY 7 0.0001
750 CELLULITIS 6 0.0001
751 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
752 OSTEOARTHRITIS 5 0.0001
753 CONFUSIONAL STATE 19 0.0001
754 HYPOPHAGIA 3 0.0001
755 HAEMATURIA 4 0.0001
756 CARDIAC MURMUR 1 0.0001
757 MUCOSAL INFLAMMATION 3 0.0001
758 SPEECH DISORDER 6 0.0001
759 MUSCULOSKELETAL STIFFNESS 10 0.0001
760 HYPERKALAEMIA 4 0.0001
761 DRUG INTOLERANCE 11 0.0001
762 CARDIAC FAILURE CONGESTIVE 9 0.0001
763 THIRST 2 0.0001
764 PULMONARY OEDEMA 5 0.0001
765 FEAR 3 0.0001
766 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
767 GASTROENTERITIS VIRAL 2 0.0001
768 TOOTHACHE 2 0.0001
769 C-REACTIVE PROTEIN INCREASED 4 0.0001
770 HYPERGLYCAEMIA 4 0.0001
771 BRAIN NEOPLASM 1 0.0001
772 TINNITUS 5 0.0001
773 SKIN DISCOLOURATION 5 0.0001
774 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
775 ADVERSE EVENT 10 0.0001
776 CONJUNCTIVITIS 2 0.0001
777 DEEP VEIN THROMBOSIS 7 0.0001
778 HEPATIC STEATOSIS 2 0.0001
779 DEMENTIA 3 0.0001
780 DYSARTHRIA 4 0.0001
781 HOT FLUSH 8 0.0001
782 BLOOD SODIUM DECREASED 2 0.0001
783 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
784 INFUSION RELATED REACTION 7 0.0001
785 OCULAR HYPERAEMIA 5 0.0001
786 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
787 PAIN IN EXTREMITY 31 0.0001
788 RED BLOOD CELL COUNT DECREASED 3 0.0001
789 PRODUCTIVE COUGH 5 0.0001
790 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
791 ACUTE RESPIRATORY FAILURE 2 0.0001
792 PRESCRIBED OVERDOSE 2 0.0001
793 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
794 HAEMORRHOIDS 2 0.0001
795 PLASMA CELL MYELOMA 4 0.0001
796 VISION BLURRED 14 0.0001
797 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
798 LOSS OF CONSCIOUSNESS 13 0.0001
799 PRODUCT USE ISSUE 19 0.0001
800 PREGNANCY 2 0.0001
801 SPINAL FRACTURE 2 0.0001
802 IRRITABILITY 6 0.0001
803 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
804 INTENTIONAL SELF-INJURY 2 0.0001
805 SEPSIS 11 0.0001
806 TASTE DISORDER 2 0.0001
807 THROMBOCYTOPENIA 11 0.0001
808 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
809 FATIGUE 76 0.0001
810 EMOTIONAL DISORDER 3 0.0001
811 MUSCULAR WEAKNESS 11 0.0001
812 TOOTH LOSS 2 0.0001
813 PULMONARY HYPERTENSION 2 0.0001
814 RESPIRATORY FAILURE 7 0.0001
815 AGITATION 7 0.0001
816 WITHDRAWAL SYNDROME 4 0.0001
817 HALLUCINATION, VISUAL 2 0.0001
818 ANAEMIA 18 0.0001
819 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
820 BREAST PAIN 1 0.0001
821 JOINT INJURY 2 0.0001
822 BODY HEIGHT DECREASED 1 0.0001
823 MOVEMENT DISORDER 3 0.0001
824 NIGHT SWEATS 3 0.0001
825 DISEASE PROGRESSION 11 0.0001
826 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
827 PRODUCT DISPENSING ERROR 2 0.0001
828 DIABETES MELLITUS 7 0.0001
829 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
830 ASPIRATION 1 0.0001
831 BLOOD GLUCOSE FLUCTUATION 1 0.0001
832 EYE DISORDER 3 0.0001
833 VISUAL ACUITY REDUCED 3 0.0001
834 FUNGAL INFECTION 3 0.0001
835 TRANSAMINASES INCREASED 2 0.0001
836 BLISTER 5 0.0001
837 ASTHMA 10 0.0001
838 SUICIDAL IDEATION 8 0.0001
839 NIGHTMARE 3 0.0001
840 PNEUMONIA 28 0.0001
841 DELIRIUM 3 0.0001
842 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
843 RASH MACULAR 3 0.0001
844 INFLUENZA LIKE ILLNESS 7 0.0001
845 CARDIAC ARREST 7 0.0001
846 BLOOD IRON DECREASED 1 0.0001
847 DISEASE RECURRENCE 4 0.0001
848 SKIN BURNING SENSATION 6 0.0001
849 ACCIDENT 1 0.0001
850 GAIT DISTURBANCE 16 0.0001
851 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
852 SUICIDE ATTEMPT 5 0.0001
853 ADRENAL INSUFFICIENCY 1 0.0001
854 PYREXIA 28 0.0001
855 NEUTROPENIA 11 0.0001
856 VISUAL IMPAIRMENT 10 0.0001
857 HEPATIC FUNCTION ABNORMAL 3 0.0001
858 SYNCOPE 8 0.0001
859 DRUG WITHDRAWAL SYNDROME 7 0.0001
860 DYSPNOEA EXERTIONAL 3 0.0001
861 BRAIN OEDEMA 1 0.0001
862 COLITIS 3 0.0001
863 PRODUCT COMPLAINT 2 0.0001
864 SINUSITIS 8 0.0001
865 ANAPHYLACTIC SHOCK 2 0.0001
866 HAEMATOMA 2 0.0001
867 DIPLOPIA 2 0.0001
868 CEREBROVASCULAR ACCIDENT 13 0.0001
869 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
870 BEDRIDDEN 1 0.0001
871 ANKYLOSING SPONDYLITIS 1 0.0001
872 ABNORMAL BEHAVIOUR 3 0.0001
873 ABORTION SPONTANEOUS 3 0.0001
874 CARDIAC DISORDER 7 0.0001
875 MYOCARDIAL INFARCTION 13 0.0001
876 LIMB INJURY 2 0.0001
877 NEUTROPHIL COUNT DECREASED 3 0.0001
878 TREATMENT NONCOMPLIANCE 4 0.0001
879 DIVERTICULITIS 2 0.0001
880 RHABDOMYOLYSIS 3 0.0001
881 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
882 COORDINATION ABNORMAL 1 0.0001
883 APHONIA 1 0.0001
884 WOUND 2 0.0001
885 CARPAL TUNNEL SYNDROME 1 0.0001
886 OXYGEN SATURATION DECREASED 4 0.0001
887 BLOOD TEST ABNORMAL 1 0.0001
888 EYE PAIN 4 0.0001
889 NASOPHARYNGITIS 13 0.0001
890 HYPERSOMNIA 2 0.0001
891 HERPES ZOSTER 4 0.0001
892 VAGINAL HAEMORRHAGE 3 0.0001
893 ANOSMIA 1 0.0001
894 DECREASED APPETITE 16 0.0001
895 FLUSHING 7 0.0001
896 LIVER FUNCTION TEST ABNORMAL 2 0.0001
897 DYSSTASIA 2 0.0001
898 BONE PAIN 4 0.0001
899 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
900 ASCITES 2 0.0001
901 PSYCHOTIC DISORDER 2 0.0001
902 CARDIOMYOPATHY 1 0.0001
903 WEIGHT INCREASED 15 0.0001
904 HAEMORRHAGE 7 0.0001
905 ADVERSE DRUG REACTION 6 0.0001
906 BLOOD POTASSIUM DECREASED 2 0.0001
907 APHASIA 2 0.0001
908 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
909 EPILEPSY 2 0.0001
910 ARTHRALGIA 27 0.0001
911 HYPOTENSION 13 0.0001
912 LIMB DISCOMFORT 2 0.0001
913 ACUTE MYELOID LEUKAEMIA 1 0.0001
914 BASAL CELL CARCINOMA 1 0.0001
915 DRUG-INDUCED LIVER INJURY 2 0.0001
916 ARTHRITIS 5 0.0001
917 ARRHYTHMIA 3 0.0001
918 METABOLIC ACIDOSIS 2 0.0001
919 BACK DISORDER 1 0.0001
920 TREATMENT FAILURE 5 0.0001
921 CYTOMEGALOVIRUS INFECTION 1 0.0001
922 DRUG ABUSE 5 0.0001
923 AGGRESSION 3 0.0001
924 ANGER 2 0.0001
925 ILLNESS 6 0.0001
926 ECZEMA 3 0.0001
927 FALL 19 0.0001
928 AMENORRHOEA 1 0.0001
929 HEART RATE DECREASED 2 0.0001
930 DEPRESSED MOOD 3 0.0001
931 DRUG INTERACTION 9 0.0001
932 DRUG DEPENDENCE 9 0.0001
933 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
934 CEREBRAL HAEMORRHAGE 2 0.0001
935 BONE DISORDER 1 0.0001
936 PANIC ATTACK 2 0.0001
937 BLOOD GLUCOSE ABNORMAL 1 0.0001
938 BRONCHITIS 4 0.0001
939 PANCYTOPENIA 3 0.0001
940 INTESTINAL OBSTRUCTION 2 0.0001
941 NEUROPATHY PERIPHERAL 5 0.0001
942 EYE IRRITATION 3 0.0001
943 MEMORY IMPAIRMENT 7 0.0001
944 CATARACT 3 0.0001
945 THROMBOSIS 4 0.0000
946 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
947 OFF LABEL USE 42 0.0000
948 ROAD TRAFFIC ACCIDENT 2 0.0000
949 DERMATITIS 1 0.0000
950 INTENTIONAL OVERDOSE 3 0.0000
951 BALANCE DISORDER 4 0.0000
952 PRODUCT STORAGE ERROR 4 0.0000
953 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
954 APPLICATION SITE PAIN 1 0.0000
955 DRY SKIN 6 0.0000
956 INFLUENZA 5 0.0000
957 COLITIS ULCERATIVE 2 0.0000
958 THERAPY NON-RESPONDER 2 0.0000
959 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
960 RHEUMATOID ARTHRITIS 5 0.0000
961 HYPOKALAEMIA 2 0.0000
962 CEREBRAL INFARCTION 1 0.0000
963 LUNG DISORDER 2 0.0000
964 ABDOMINAL PAIN LOWER 1 0.0000
965 CARDIOVASCULAR DISORDER 1 0.0000
966 INFLAMMATION 2 0.0000
967 APPLICATION SITE ERYTHEMA 1 0.0000
968 PRODUCT QUALITY ISSUE 5 0.0000
969 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
970 PERIPHERAL SWELLING 5 0.0000
971 FEBRILE NEUTROPENIA 2 0.0000
972 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
973 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
974 INFECTION 4 0.0000
975 UNDERDOSE 2 0.0000
976 DEATH 23 0.0000
977 ACNE 2 0.0000
978 HOSPITALISATION 4 0.0000
979 CARDIAC FAILURE 2 0.0000
980 BLINDNESS 1 0.0000
981 DRUG DOSE OMISSION 4 0.0000
982 COMPLETED SUICIDE 2 0.0000
983 SKIN EXFOLIATION 2 0.0000
984 PSORIASIS 3 0.0000
985 ANGIOEDEMA 1 0.0000
986 COGNITIVE DISORDER 1 0.0000
987 BRADYCARDIA 1 0.0000
988 ARTHROPATHY 1 0.0000
989 COVID-19 2 0.0000
990 PRODUCT DOSE OMISSION ISSUE 2 0.0000
991 INJECTION SITE PAIN 2 0.0000